Atai Capital returned 3.1% in the fourth quarter, bringing our full-year 2024 returns to 7.7% net of all fees. Click here to ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.

JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved… accelant, a leader in sales, marketing, and revenue operations, is thrilled to announc ...

Researchers have introduced genetic material into plants via their roots, opening a potential pathway for rapid crop improvement.